Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Combined treatment of cisplatin and overexpression of caspase-activated deoxyribonuclease (CAD) promotes apoptosis in vitro and in vivo.

Kimura Y, Sugimoto C, Matsukawa S, Sunaga H, Igawa H, Yamamoto H, Ito T, Saito H, Fujieda S.

Oral Oncol. 2004 Apr;40(4):390-9.

PMID:
14969818
2.

Head and neck squamous cell carcinoma targeted chemosensitization.

Figures MR, Wobb J, Araki K, Liu T, Xu L, Zhu H, O'Malley BW Jr, Li D.

Otolaryngol Head Neck Surg. 2009 Aug;141(2):177-83. doi: 10.1016/j.otohns.2009.04.024.

PMID:
19643248
3.

[Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin].

Zhang Y, Lin C, Qian HL, Lang JH, Fu M, Zhang XY, Liang X, Duan H, Xiang Y.

Zhonghua Zhong Liu Za Zhi. 2007 Jan;29(1):25-9. Chinese.

PMID:
17575689
4.

Interleukin 2 gene transfer prevents NKG2D suppression and enhances antitumor efficacy in combination with cisplatin for head and neck squamous cell cancer.

Li D, Ronson B, Guo M, Liu S, Bishop JS, Van Echo DA, O'Malley BW Jr.

Cancer Res. 2002 Jul 15;62(14):4023-8.

5.

Enhancement of Cisplatin sensitivity in squamous cell carcinoma of the head and neck transfected with a survivin antisense gene.

Kojima H, Iida M, Yaguchi Y, Suzuki R, Hayashi N, Moriyama H, Manome Y.

Arch Otolaryngol Head Neck Surg. 2006 Jun;132(6):682-5.

PMID:
16785416
6.

PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.

Yuan Z, Yan F, Wang YS, Liu HY, Gou LT, Zhao XY, Lai ST, Deng HX, Li J, Ding ZY, Xiong SQ, Kan B, Mao YQ, Chen LJ, Wei YQ, Zhao X.

Cancer Chemother Pharmacol. 2009 Dec;65(1):13-25. doi: 10.1007/s00280-009-0998-5. Epub 2009 Apr 22.

PMID:
19387645
7.

Major histocompatibility gene therapy: the importance of haplotype and beta 2-microglobulin.

Salamone FN, Gleich LL, Li YQ, Stambrook PJ.

Laryngoscope. 2004 Apr;114(4):612-5.

PMID:
15064612
8.

[IL-2 gene and cisplatin combined therapy for head and neck squamous cell carcinoma].

Liu S, Lin Y, Tang S, Yang H, Liang C.

Hua Xi Kou Qiang Yi Xue Za Zhi. 2001 Jun;19(3):191-3. Chinese.

9.

Adenovirus-mediated expression of dominant negative c-myb induces apoptosis in head and neck cancer cells and inhibits tumor growth in animal model.

Kim SY, Yang YS, Hong KH, Jang KY, Chung MJ, Lee DY, Lee JC, Yi HK, Nam SY, Hwang PH.

Oral Oncol. 2008 Apr;44(4):383-92. Epub 2007 Aug 8.

PMID:
17690006
10.

Combined VSV oncolytic virus and chemotherapy for squamous cell carcinoma.

Sung CK, Choi B, Wanna G, Genden EM, Woo SL, Shin EJ.

Laryngoscope. 2008 Feb;118(2):237-42.

PMID:
18043494
11.

Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.

O'Malley BW Jr, Li D, McQuone SJ, Ralston R.

Laryngoscope. 2005 Mar;115(3):391-404.

PMID:
15744147
12.
13.
14.

Loss of caspase-8 activation pathway is a possible mechanism for CDDP resistance in human laryngeal squamous cell carcinoma, HEp-2 cells.

Toyozumi Y, Arima N, Izumaru S, Kato S, Morimatsu M, Nakashima T.

Int J Oncol. 2004 Sep;25(3):721-8.

PMID:
15289875
15.

Apoptosis-promoting gene (bax) transfer potentiates sensitivity of squamous cell carcinoma to cisplatin in vitro and in vivo.

Sugimoto C, Fujieda S, Seki M, Sunaga H, Fan GK, Tsuzuki H, Borner C, Saito H, Matsukawa S.

Int J Cancer. 1999 Sep 9;82(6):860-7.

16.

FasL gene therapy: a new therapeutic modality for head and neck cancer.

ElOjeimy S, McKillop JC, El-Zawahry AM, Holman DH, Liu X, Schwartz DA, Day TA, Dong JY, Norris JS.

Cancer Gene Ther. 2006 Aug;13(8):739-45. Epub 2006 Mar 17.

PMID:
16543918
17.
18.

Effect of Ad-p16 combined with CDDP or As2O3 on human bladder cancer cells.

Zhu Z, Xing S, Lin C.

J Huazhong Univ Sci Technolog Med Sci. 2003;23(2):169-72.

PMID:
12973940
19.

Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck.

Kim SH, Wong RJ, Kooby DA, Carew JF, Adusumilli PS, Patel SG, Shah JP, Fong Y.

Eur J Cancer. 2005 Jan;41(2):313-22.

PMID:
15661558
20.

Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.

Andrews GA, Xi S, Pomerantz RG, Lin CJ, Gooding WE, Wentzel AL, Wu L, Sidransky D, Grandis JR.

Head Neck. 2004 Oct;26(10):870-7.

PMID:
15390206

Supplemental Content

Support Center